Skip to main content
Erschienen in: World Journal of Surgery 6/2010

01.06.2010

Five-year Follow-up of a Randomized Clinical Trial of Total Thyroidectomy versus Dunhill Operation versus Bilateral Subtotal Thyroidectomy for Multinodular Nontoxic Goiter

verfasst von: Marcin Barczyński, Aleksander Konturek, Alicja Hubalewska-Dydejczyk, Filip Gołkowski, Stanisław Cichoń, Wojciech Nowak

Erschienen in: World Journal of Surgery | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The extent of thyroid resection in multinodular nontoxic goiter (MNG) is controversial. The aim of the present study was to evaluate results of various thyroid resection modes, with special emphasis put on the recurrence rate and morbidity rate, in a 5-year follow-up.

Materials and methods

From 01/2000 through 12/2003, 600 consenting patients with MNG qualified for thyroidectomy at our institution were randomized to three groups equal in size, n = 200 in each. Patients in group A underwent total thyroidectomy (TT); patients in group B underwent Dunhill operation (DO), whereas patients in group C underwent bilateral subtotal thyroidectomy (BST). All patients were subjected to ultrasonographic, cytological, and biochemical follow-up at least for 60 months postoperatively. The primary outcome measure was prevalence of recurrent goiter and need for redo surgery. The secondary outcome measure was the postoperative morbidity rate (hypoparathyroidism and recurrent laryngeal nerve injury).

Results

Recurrent goiter was found in 0.52% TT versus 4.71% DO versus 11.58% BST (p = 0.01 for TT versus DO, p = 0.02 for DO versus BST, p < 0.001 for TT versus BST), and completion thyroidectomy was necessary in 0.52% TT versus 1.57% DO versus 3.68% BST (p = 0.03 for TT versus BST). Transient postoperative hypoparathyroidism was present in 10.99% versus 4.23% versus 2.1% (p = 0.007 for TT versus DO, p < 0.001 for TT versus BST), whereas the recurrent laryngeal nerve injury rate was 5.49% and 1.05% TT versus 4.23% and 0.79% DO versus 2.1% and 0.53% BST (transient and permanent, respectively; p = 0.007 for transient events TT versus BST).

Conclusions

Total thyroidectomy can be regarded as the procedure of choice for patients with MNG. It is associated with a significantly lower incidence of goiter recurrence and less frequent need for completion thyroidectomy than other more limited thyroid resections. However, TT involves a significantly higher risk of postoperative transient but not permanent hypoparathyroidism and recurrent laryngeal nerve paresis.
Literatur
1.
Zurück zum Zitat Liu Q, Djuricin G, Prinz RA (1998) Total thyroidectomy for benign thyroid disease. Surgery 123:2–7PubMed Liu Q, Djuricin G, Prinz RA (1998) Total thyroidectomy for benign thyroid disease. Surgery 123:2–7PubMed
2.
Zurück zum Zitat Ozbas S, Kocak S, Aydintug S et al (2005) Comparison of the complications of subtotal, near total and total thyroidectomy in the surgical management of multinodular goitre. Endocr J 52:199–205CrossRefPubMed Ozbas S, Kocak S, Aydintug S et al (2005) Comparison of the complications of subtotal, near total and total thyroidectomy in the surgical management of multinodular goitre. Endocr J 52:199–205CrossRefPubMed
3.
Zurück zum Zitat Thomusch O, Machens A, Sekulla C et al (2000) Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg 24:1335–1341CrossRefPubMed Thomusch O, Machens A, Sekulla C et al (2000) Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg 24:1335–1341CrossRefPubMed
4.
5.
Zurück zum Zitat Bellantone R, Lombardi CP, Bossola M et al (2002) Total thyroidectomy for management of benign thyroid disease: review of 526 cases. World J Surg 26:1468–1471CrossRefPubMed Bellantone R, Lombardi CP, Bossola M et al (2002) Total thyroidectomy for management of benign thyroid disease: review of 526 cases. World J Surg 26:1468–1471CrossRefPubMed
6.
Zurück zum Zitat Thomusch O, Sekulla C, Dralle H (2003) Is primary total thyroidectomy justified in benign multinodular goiter? Results of a prospective quality assurance study of 45 hospitals offering different levels of care. Chirurg 74:437–443CrossRefPubMed Thomusch O, Sekulla C, Dralle H (2003) Is primary total thyroidectomy justified in benign multinodular goiter? Results of a prospective quality assurance study of 45 hospitals offering different levels of care. Chirurg 74:437–443CrossRefPubMed
7.
Zurück zum Zitat Moalem J, Suh I, Duh QY (2008) Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature. World J Surg 32:1301–1312CrossRefPubMed Moalem J, Suh I, Duh QY (2008) Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature. World J Surg 32:1301–1312CrossRefPubMed
8.
Zurück zum Zitat Giles Y, Boztepe H, Terzioglu T et al (2004) The advantage of total thyroidectomy to avoid reoperation for incidental thyroid cancer in multinodular goiter. Arch Surg 139:179–182CrossRefPubMed Giles Y, Boztepe H, Terzioglu T et al (2004) The advantage of total thyroidectomy to avoid reoperation for incidental thyroid cancer in multinodular goiter. Arch Surg 139:179–182CrossRefPubMed
9.
Zurück zum Zitat Tezelman S, Borucu I, Senyurek Y et al (2009) The change in surgical practice from subtotal to near-total or total thyroidectomy in the treatment of patients with benign multinodular goiter. World J Surg 33:400–405CrossRefPubMed Tezelman S, Borucu I, Senyurek Y et al (2009) The change in surgical practice from subtotal to near-total or total thyroidectomy in the treatment of patients with benign multinodular goiter. World J Surg 33:400–405CrossRefPubMed
10.
Zurück zum Zitat Delbridge L, Guinea AI, Reeve TS (1999) Total thyroidectomy for bilateral benign multinodular goiter: effect of changing practice. Arch Surg 134:1389–1393CrossRefPubMed Delbridge L, Guinea AI, Reeve TS (1999) Total thyroidectomy for bilateral benign multinodular goiter: effect of changing practice. Arch Surg 134:1389–1393CrossRefPubMed
12.
Zurück zum Zitat Efremidou EI, Papageorgiou MS, Liratzopoulos N et al (2009) The efficacy and safety of total thyroidectomy in the management of benign thyroid disease: a review of 932 cases. Can J Surg 52:39–44PubMed Efremidou EI, Papageorgiou MS, Liratzopoulos N et al (2009) The efficacy and safety of total thyroidectomy in the management of benign thyroid disease: a review of 932 cases. Can J Surg 52:39–44PubMed
13.
Zurück zum Zitat Gough IR, Wilkinson D (2000) Total thyroidectomy for management of thyroid disease. World J Surg 24:962–965CrossRefPubMed Gough IR, Wilkinson D (2000) Total thyroidectomy for management of thyroid disease. World J Surg 24:962–965CrossRefPubMed
14.
Zurück zum Zitat Mishra A, Agarwal A, Agarwal G et al (2001) Total thyroidectomy in benign thyroid disorders in an endemic region. World J Surg 25:307–310CrossRefPubMed Mishra A, Agarwal A, Agarwal G et al (2001) Total thyroidectomy in benign thyroid disorders in an endemic region. World J Surg 25:307–310CrossRefPubMed
15.
Zurück zum Zitat Agarwal G, Aggarwal V (2008) Is total thyroidectomy the surgical procedure of choice for benign multinodular goiter? An evidence-based review. World J Surg 32:1313–1324CrossRefPubMed Agarwal G, Aggarwal V (2008) Is total thyroidectomy the surgical procedure of choice for benign multinodular goiter? An evidence-based review. World J Surg 32:1313–1324CrossRefPubMed
16.
Zurück zum Zitat Delbridge L (2008) Symposium on evidence-based endocrine surgery (2): benign thyroid disease. World J Surg 32:1235–1236CrossRefPubMed Delbridge L (2008) Symposium on evidence-based endocrine surgery (2): benign thyroid disease. World J Surg 32:1235–1236CrossRefPubMed
17.
Zurück zum Zitat Wells SA Jr, Gunnells JC, Shelburne JD et al (1975) Transplantation of the parathyroid glands in man: clinical indications and results. Surgery 78:34–44PubMed Wells SA Jr, Gunnells JC, Shelburne JD et al (1975) Transplantation of the parathyroid glands in man: clinical indications and results. Surgery 78:34–44PubMed
18.
Zurück zum Zitat Miccoli P, Antonelli A, Iacconi P et al (1993) Prospective, randomized, double-blind study about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: results at the third year of follow up. Surgery 114:1097–1101PubMed Miccoli P, Antonelli A, Iacconi P et al (1993) Prospective, randomized, double-blind study about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: results at the third year of follow up. Surgery 114:1097–1101PubMed
19.
Zurück zum Zitat Ríos A, Rodríguez JM, Canteras M et al (2005) Surgical management of multinodular goiter with compression symptoms. Arch Surg 140:49–53CrossRefPubMed Ríos A, Rodríguez JM, Canteras M et al (2005) Surgical management of multinodular goiter with compression symptoms. Arch Surg 140:49–53CrossRefPubMed
20.
Zurück zum Zitat Kraimps JL, Marechaud R, Gineste D et al (1993) Analysis and prevention of recurrent goiter. Surg Gynecol Obstet 176:319–322PubMed Kraimps JL, Marechaud R, Gineste D et al (1993) Analysis and prevention of recurrent goiter. Surg Gynecol Obstet 176:319–322PubMed
21.
Zurück zum Zitat Gibelin H, Sierra M, Mothes D et al (2004) Risk factors for recurrent nodular goiter after thyroidectomy for benign disease: case-control study of 244 patients. World J Surg 28:1079–1082CrossRefPubMed Gibelin H, Sierra M, Mothes D et al (2004) Risk factors for recurrent nodular goiter after thyroidectomy for benign disease: case-control study of 244 patients. World J Surg 28:1079–1082CrossRefPubMed
22.
Zurück zum Zitat Bistrup C, Nielsen JD, Gregersen G et al (1994) Preventive effect of levothyroxine in patients operated for nontoxic goitre: a randomized trial of one hundred patients with nine years follow-up. Clin Endocrinol 40:323–327 Bistrup C, Nielsen JD, Gregersen G et al (1994) Preventive effect of levothyroxine in patients operated for nontoxic goitre: a randomized trial of one hundred patients with nine years follow-up. Clin Endocrinol 40:323–327
23.
Zurück zum Zitat Anderson PE, Hurley PR, Rosswick P (1990) Conservative treatment and long term prophylactic thyroxine in the prevention of recurrence of multinodular goiter. Surg Gynecol Obstet 171:309–314PubMed Anderson PE, Hurley PR, Rosswick P (1990) Conservative treatment and long term prophylactic thyroxine in the prevention of recurrence of multinodular goiter. Surg Gynecol Obstet 171:309–314PubMed
24.
Zurück zum Zitat Torre G, Barreca A, Borgonovo G et al (2000) Goiter recurrence in patients submitted to thyroid-stimulating hormone suppression: possible role of insulin-like growth factors and insulin-like growth factor-binding proteins. Surgery 127:99–103CrossRefPubMed Torre G, Barreca A, Borgonovo G et al (2000) Goiter recurrence in patients submitted to thyroid-stimulating hormone suppression: possible role of insulin-like growth factors and insulin-like growth factor-binding proteins. Surgery 127:99–103CrossRefPubMed
25.
Zurück zum Zitat Seiler CA, Glaser C, Wagner HE (1996) Thyroid gland surgery in an endemic region. World J Surg 20:593–596CrossRefPubMed Seiler CA, Glaser C, Wagner HE (1996) Thyroid gland surgery in an endemic region. World J Surg 20:593–596CrossRefPubMed
26.
Zurück zum Zitat Erbil Y, Bozbora A, Yanik BT et al (2007) Predictive factors for recurrent non-toxic goitre in an endemic region. J Laryngol Otol 121:231–236CrossRefPubMed Erbil Y, Bozbora A, Yanik BT et al (2007) Predictive factors for recurrent non-toxic goitre in an endemic region. J Laryngol Otol 121:231–236CrossRefPubMed
27.
Zurück zum Zitat Hegedus L, Hansen JM, Veiergang D et al (1987) Does prophylactic thyroxine treatment after operation for non-toxic goiter influence thyroid size? Br Med J 294:801–803CrossRef Hegedus L, Hansen JM, Veiergang D et al (1987) Does prophylactic thyroxine treatment after operation for non-toxic goiter influence thyroid size? Br Med J 294:801–803CrossRef
28.
Zurück zum Zitat Snook KL, Stalberg PL, Sidhu SB et al (2007) Recurrence after total thyroidectomy for benign multinodular goiter. World J Surg 31:593–599CrossRefPubMed Snook KL, Stalberg PL, Sidhu SB et al (2007) Recurrence after total thyroidectomy for benign multinodular goiter. World J Surg 31:593–599CrossRefPubMed
29.
Zurück zum Zitat Wilson DB, Staren ED, Prinz RA (1998) Thyroid reoperations: indications and risks. Am Surg 64:674–678PubMed Wilson DB, Staren ED, Prinz RA (1998) Thyroid reoperations: indications and risks. Am Surg 64:674–678PubMed
30.
Zurück zum Zitat Marchesi M, Biffoni M, Tartaglia F et al (1998) Total versus subtotal thyroidectomy in the management of multinodular goiter. Int Surg 83:202–204PubMed Marchesi M, Biffoni M, Tartaglia F et al (1998) Total versus subtotal thyroidectomy in the management of multinodular goiter. Int Surg 83:202–204PubMed
31.
Zurück zum Zitat Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 19:1167–1214CrossRefPubMed Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 19:1167–1214CrossRefPubMed
32.
Zurück zum Zitat Reeve TS, Delbridge L, Brady P et al (1988) Secondary thyroidectomy: a twenty-year experience. World J Surg 12:449–453CrossRefPubMed Reeve TS, Delbridge L, Brady P et al (1988) Secondary thyroidectomy: a twenty-year experience. World J Surg 12:449–453CrossRefPubMed
33.
Zurück zum Zitat Rojdmark J, Jarhult J (1995) High long term recurrence rate after subtotal thyroidectomy for nodular goitre. Eur J Surg 161:725–727PubMed Rojdmark J, Jarhult J (1995) High long term recurrence rate after subtotal thyroidectomy for nodular goitre. Eur J Surg 161:725–727PubMed
34.
Zurück zum Zitat Phitayakorn R, McHenry CR (2008) Follow-up after surgery for benign nodular thyroid disease: evidence-based approach. World J Surg 32:1374–1384CrossRefPubMed Phitayakorn R, McHenry CR (2008) Follow-up after surgery for benign nodular thyroid disease: evidence-based approach. World J Surg 32:1374–1384CrossRefPubMed
35.
Zurück zum Zitat Arora N, Scognamiglio T, Zhu B et al (2008) Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg 32:1237–1246CrossRefPubMed Arora N, Scognamiglio T, Zhu B et al (2008) Do benign thyroid nodules have malignant potential? An evidence-based review. World J Surg 32:1237–1246CrossRefPubMed
36.
Zurück zum Zitat Szybinski Z, Golkowski F, Buziak-Bereza M et al (2008) Effectiveness of the iodine prophylaxis model adopted in Poland. J Endocrinol Invest 31:309–313PubMed Szybinski Z, Golkowski F, Buziak-Bereza M et al (2008) Effectiveness of the iodine prophylaxis model adopted in Poland. J Endocrinol Invest 31:309–313PubMed
37.
Zurück zum Zitat Carella C, Mazziotti G, Rotondi M et al (2002) Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study. Clin Endocrinol 57:507–513CrossRef Carella C, Mazziotti G, Rotondi M et al (2002) Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study. Clin Endocrinol 57:507–513CrossRef
38.
Zurück zum Zitat Gerard AC, Poncin S, Caetano B et al (2008) Iodine deficiency and genitourinary pathobiology. Am J Pathol 172:748–760CrossRefPubMed Gerard AC, Poncin S, Caetano B et al (2008) Iodine deficiency and genitourinary pathobiology. Am J Pathol 172:748–760CrossRefPubMed
39.
Zurück zum Zitat Teuscher J, Peter H, Gerber HJ et al (1988) Pathogenesis of nodular goiter and its application for surgical treatment. Surgery 103:87–93PubMed Teuscher J, Peter H, Gerber HJ et al (1988) Pathogenesis of nodular goiter and its application for surgical treatment. Surgery 103:87–93PubMed
40.
Zurück zum Zitat Harrer P, Broecker M, Zint A et al (1998) Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal. J Endocrinol Invest 21:380–385PubMed Harrer P, Broecker M, Zint A et al (1998) Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal. J Endocrinol Invest 21:380–385PubMed
41.
Zurück zum Zitat Harrer P, Brocker M, Zint A et al (1998) The clonality of nodules in recurrent goiters at second surgery. Langenbecks Arch Surg 383:453–455CrossRefPubMed Harrer P, Brocker M, Zint A et al (1998) The clonality of nodules in recurrent goiters at second surgery. Langenbecks Arch Surg 383:453–455CrossRefPubMed
42.
Zurück zum Zitat Reeve TS, Curtin A, Fingleton L et al (1994) Can total thyroidectomy be performed as safely by general surgeons in provincial centers as by surgeons in specialized endocrine surgical units? Making the case for surgical training. Arch Surg 129:834–836PubMed Reeve TS, Curtin A, Fingleton L et al (1994) Can total thyroidectomy be performed as safely by general surgeons in provincial centers as by surgeons in specialized endocrine surgical units? Making the case for surgical training. Arch Surg 129:834–836PubMed
43.
Zurück zum Zitat Sosa JA, Bowman HM, Tielsch JM et al (1998) The importance of surgeon experience for the clinical and economic outcomes from thyroidectomy. Ann Surg 228:320–330CrossRefPubMed Sosa JA, Bowman HM, Tielsch JM et al (1998) The importance of surgeon experience for the clinical and economic outcomes from thyroidectomy. Ann Surg 228:320–330CrossRefPubMed
44.
Zurück zum Zitat Harness JK, Organ CH Jr, Thompson NW (1995) Operative experience of US general surgery residents in thyroid and parathyroid disease. Surgery 118:1063–1069CrossRefPubMed Harness JK, Organ CH Jr, Thompson NW (1995) Operative experience of US general surgery residents in thyroid and parathyroid disease. Surgery 118:1063–1069CrossRefPubMed
46.
Zurück zum Zitat Bilimoria K, Bentrem D, Linn JG et al (2007) Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery 142:906–913CrossRefPubMed Bilimoria K, Bentrem D, Linn JG et al (2007) Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery 142:906–913CrossRefPubMed
47.
Zurück zum Zitat Pattou F, Combemale F, Fabre S et al (1998) Hypocalcaemia following thyroid surgery incidence and prediction of outcome. World J Surg 22:718–724CrossRefPubMed Pattou F, Combemale F, Fabre S et al (1998) Hypocalcaemia following thyroid surgery incidence and prediction of outcome. World J Surg 22:718–724CrossRefPubMed
48.
Zurück zum Zitat Steurer M, Passler C, Denk DM et al (2002) Advantages of recurrent laryngeal nerve identification in thyroidectomy and parathyroidectomy and the importance of preoperative and postoperative laryngoscopic examination in more than 1000 nerves at risk. Laryngoscope 112:124–133CrossRefPubMed Steurer M, Passler C, Denk DM et al (2002) Advantages of recurrent laryngeal nerve identification in thyroidectomy and parathyroidectomy and the importance of preoperative and postoperative laryngoscopic examination in more than 1000 nerves at risk. Laryngoscope 112:124–133CrossRefPubMed
50.
Zurück zum Zitat Thomusch O, Sekulla C, Walls G et al (2002) Intraoperative neuromonitoring of surgery for benign goiter. Am J Surg 183:673–678CrossRefPubMed Thomusch O, Sekulla C, Walls G et al (2002) Intraoperative neuromonitoring of surgery for benign goiter. Am J Surg 183:673–678CrossRefPubMed
51.
Zurück zum Zitat Dralle H, Sekulla C, Lorenz K et al (2008) German IONM Study Group. Intraoperative monitoring of the recurrent laryngeal nerve in thyroid surgery. World J Surg 32:1358–1366CrossRefPubMed Dralle H, Sekulla C, Lorenz K et al (2008) German IONM Study Group. Intraoperative monitoring of the recurrent laryngeal nerve in thyroid surgery. World J Surg 32:1358–1366CrossRefPubMed
52.
Zurück zum Zitat Barczyński M, Konturek A, Cichoń S (2009) Randomized clinical trial of visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy. Br J Surg 96:240–246CrossRefPubMed Barczyński M, Konturek A, Cichoń S (2009) Randomized clinical trial of visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy. Br J Surg 96:240–246CrossRefPubMed
53.
Zurück zum Zitat Horne SK, Gal TJ, Brennan JA (2007) Prevalence and patterns of intraoperative nerve monitoring for thyroidectomy. Otolaryngol Head Neck Surg 136:952–956CrossRefPubMed Horne SK, Gal TJ, Brennan JA (2007) Prevalence and patterns of intraoperative nerve monitoring for thyroidectomy. Otolaryngol Head Neck Surg 136:952–956CrossRefPubMed
Metadaten
Titel
Five-year Follow-up of a Randomized Clinical Trial of Total Thyroidectomy versus Dunhill Operation versus Bilateral Subtotal Thyroidectomy for Multinodular Nontoxic Goiter
verfasst von
Marcin Barczyński
Aleksander Konturek
Alicja Hubalewska-Dydejczyk
Filip Gołkowski
Stanisław Cichoń
Wojciech Nowak
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 6/2010
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0491-7

Weitere Artikel der Ausgabe 6/2010

World Journal of Surgery 6/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.